Day: August 1, 2024

Growth across all service lines and segments Second quarter and year to date operating highlights:  Three months ended   Six months ended  June 30   June 30(in millions of US$, except EPS)   2024     2023       2024     2023                         Revenues $ 1,139.4   $ 1,078.0     $ 2,141.3   $ 2,043.9  Adjusted EBITDA (note 1)   155.6     147.1       264.3     251.7  Adjusted EPS (note 2)   1.36     1.31       2.13     2.16                         GAAP operating earnings   114.7     75.3       158.1     97.4  GAAP diluted net earnings (loss) per share   0.73     (0.16 )     0.99     (0.61 )TORONTO, Aug. 01, 2024 (GLOBE NEWSWIRE) — Colliers International Group Inc. (NASDAQ and TSX: CIGI) (“Colliers” or the “Company”) today announced operating and financial results for the second quarter ended...

NORCROSS, Ga., Aug. 01, 2024 (GLOBE NEWSWIRE) — CoreCard Corporation (NYSE: CCRD) (“CoreCard” or the “Company”), the leading provider of innovative credit technology solutions and processing services to the financial technology and services market, announced today its financial results for the quarter ended June 30, 2024. “Overall revenue of $13.8 million in the second quarter was in-line with our expectations,” said Leland Strange, CEO of CoreCard. “We continue to see encouraging results from the ongoing investment in our platform and processing capabilities, and we continue to onboard new customers that value the features and functionality offered by the CoreCard platform. The lower revenue this quarter compared to last year was primarily driven by lower license revenue and lower processing revenue from Kabbage.” Financial...

SOUTH ORANGE, NJ, Aug. 01, 2024 (GLOBE NEWSWIRE) — Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today announced that it will file its second-quarter financial results on Thursday, August 8, 2024 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as follows: Domestic access: 1 (844) 808-7106 International access: 1 (412) 317-5285 Upon joining, please ask to be joined into the Nephros conference call. An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page. Alternatively, a replay of the call may be accessed until August 15, 2024 at 1 (877) 344-7529 or 1 (412) 317-0088 for international callers and entering replay access...

End-of-treatment data presented at the EASL Congress from two Phase 2a clinical trials supports advancing imdusiran as a potential cornerstone in a HBV functional cure treatment regimen IM-PROVE I clinical trial demonstrated undetectable HBsAg in 33% of patients who were treated with 48 weeks of imdusiran and 24 weeks of IFN and in 67% of these patients with baseline HBsAg less than 1000 IU/mL Prioritizing imdusiran Phase 2b clinical development; eliminating HBV discovery efforts resulting in a reduction in workforce by 40% and extension of expected cash runway into the fourth quarter of 2026 Conference Call and Webcast Today at 8:45 AM ET WARMINSTER, Pa., Aug. 01, 2024 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...

Atlantica Reports Second Quarter 2024 Financial ResultsRevenue for the first half of 2024 reached $571.2 million, a 3.0% increase year-over-year compared with $554.6 million in the first half of 2023. Adjusted EBITDA was $407.3 million, remaining stable compared with $403.8 million in the first half of 2023. Net profit for the first half of 2024 attributable to the Company was $16.0 million, compared with a net profit of $24.7 million in the first half of 2023. Operating Cash Flow increased by 2.3% year-over-year up to $141.9 million. Quarterly dividend of $0.445 per share approved by the Board of Directors. Entered into a transaction agreement with California Buyer Limited, a private limited company controlled by Energy Capital Partners, for the acquisition of 100% of Atlantica’s shares.August 1, 2024 – Atlantica Sustainable Infrastructure...

Record second quarter revenues of $3.0 billion, up 6.8% compared to second quarter 2023 Operating income of $189 million, up 21.2% compared to second quarter 2023 Net earnings of $173 million or $4.38 diluted earnings per share Delivered Virginia-class submarine New Jersey (SSN 796) Delivered amphibious transport dock Richard M. McCool Jr. (LPD 29) Company reaffirms previously issued shipbuilding guidance1 Company raises the Mission Technologies revenue guidance range1 Company reaffirms previously issued free cash flow2 outlook1NEWPORT NEWS, Va., Aug. 01, 2024 (GLOBE NEWSWIRE) — HII (NYSE: HII) reported second quarter 2024 revenues of $3.0 billion, up 6.8% from the second quarter of 2023, driven by growth across all segments. Operating income in the second quarter of 2024 was $189 million and operating margin was 6.3%, compared...

Generated $199.7 million in 2Q 2024 revenues, including $179.1 million in U.S. net product sales$154.6 million for SYFOVRE® (pegcetacoplan injection) $24.5 million for EMPAVELI® (pegcetacoplan)Initiated a re-examination of the marketing authorization application of SYFOVRE with the European Medicines Agency (EMA); expect a final decision in 4Q 2024 Plan to report topline Phase 3 data with systemic pegcetacoplan in C3G / IC-MPGN in August 2024 Cash and cash equivalents of $360.1 million as of June 30, 2024; projected revenues and cash expected to be sufficient to fund operations to positive cash flow Management to host conference call today at 8:30 a.m. ETWALTHAM, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), today announced its second quarter 2024 financial results and business...

Second quarter cloud subscription revenue increased 19% year-over-year to $88.4 million MCLEAN, Va., Aug. 01, 2024 (GLOBE NEWSWIRE) — Appian (Nasdaq: APPN) today announced financial results for the second quarter ended June 30, 2024. “Due to enhanced functionality launched this quarter, Appian AI usage nearly doubled,” said Matt Calkins, CEO & Founder. “Looking ahead, we are accelerating our path to profitability. We now expect to achieve adjusted EBITDA breakeven for the full year 2024.” Second Quarter 2024 Financial Highlights:Revenue: Cloud subscription revenue was $88.4 million, up 19% compared to the second quarter of 2023. Total subscriptions revenue, which includes sales of our cloud subscriptions, on-premises term license subscriptions, and maintenance and support, increased 20% year-over-year to $113.0 million....

~ Announced RMAT designation for AMT-130 in Huntington’s disease and positive interim Phase I/II data demonstrating the slowing of disease progression and reductions in a key biomarker of neurodegeneration; Meeting with FDA expected in the second half of 2024 to discuss potential for expedited clinical development ~ ~ Initiated patient screening for three additional Phase I/II studies in mesial temporal lobe epilepsy, SOD1 ALS, and Fabry disease ~ ~ Today, announced an organizational restructuring intended to streamline operations; Together with the recent sale of the Lexington manufacturing facility, these changes are expected to reduce headcount by 65% and lower recurring cash burn by $75 million per year including savings from the retirement of $50 million of debt ~ ~ Strong cash position of approximately $524 million as of June 30,...

Second Quarter Total Revenue of $81.8 Million, an Increase of 8% Versus Prior Year. Total ARR of $345.8 Million, an Increase of 4% Versus Prior Year. Enterprise ARR of $253.8 Million, an Increase of 7% Versus Prior Year AUSTIN, Texas, Aug. 01, 2024 (GLOBE NEWSWIRE) — BigCommerce Holdings, Inc. (“BigCommerce”) (Nasdaq: BIGC), an open SaaS, composable ecommerce platform for fast-growing and established B2C and B2B brands and retailers, today announced financial results for its second quarter ended June 30, 2024. “The second quarter delivered results consistent with our top- and bottom-line plans,” said Brent Bellm, CEO of BigCommerce. “Revenue finished just under $82 million, up over 8% year-over-year, with profitability exceeding our expectations and operating cash flow of nearly $12 million. We delivered our largest sequential...